IRS4
White MF (1999). “The IRS-signalling system: a network of docking proteins that mediate insulin action.”. Mol. Cell. Biochem. 182 (1–2): 3–11. doi:10.1023/A:1006806722619. PMID 9609109.
“Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-I receptor-mediated signal transduction.”. J. Biol. Chem. 273 (24): 14780–7. (1998). doi:10.1074/jbc.273.24.14780. PMID 9614078.
“IRS-4 mediates protein kinase B signaling during insulin stimulation without promoting antiapoptosis.”. Mol. Cell. Biol. 20 (1): 126–38. (2000). doi:10.1128/MCB.20.1.126-138.2000. PMC 85068. PMID 10594015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC85068/.
“The insulin-like growth factor I receptor-induced interaction of insulin receptor substrate-4 and Crk-II.”. Endocrinology 142 (5): 1835–40. (2001). doi:10.1210/en.142.5.1835. PMID 11316748.
“Insulin receptor substrate 4 associates with the protein IRAS.”. J. Biol. Chem. 277 (22): 19439–47. (2002). doi:10.1074/jbc.M111838200. PMID 11912194.
“SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation.”. Mol. Cell. Biol. 22 (13): 4567–78. (2002). doi:10.1128/MCB.22.13.4567-4578.2002. PMC 133908. PMID 12052866. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC133908/.
“Insulin receptor substrate-4 is expressed in muscle tissue without acting as a substrate for the insulin receptor.”. Endocrinology 144 (4): 1211–8.